The Addition of Polychemotherapy to Adjuvant Radiotherapy in the Treatment of Non-Metastatic Uterine Sarcomas
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00162721
Recruitment Status : Unknown
Verified August 2007 by Gustave Roussy, Cancer Campus, Grand Paris. Recruitment status was: Recruiting
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Layout table for eligibility information
Ages Eligible for Study:
18 Years to 65 Years (Adult, Older Adult)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Histologically confirmed uterine sarcoma (rereading in reference centers)
Leiomyosarcoma, adenosarcoma, carcinosarcoma and high grade endometrial stromal sarcoma
All stages <= stage III (FIGO modified for endometrial carcinoma)
Full surgical exeresis
Age >= 18 years and physiological age <= 65 years
Negative extension check-up (thoracic and abdomino-pelvic TDM)